Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | AMGN | BMY | GILD | VRTX |
| Company | Adaptimmune Ther ADR | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.1300 | 312.89 | 44.75 | 64.72 | 420.67 |
| High | 1.2100 | 314.89 | 44.97 | 66.20 | 423.32 |
| Low | 1.0800 | 309.82 | 44.30 | 64.67 | 417.50 |
| Last | 1.1200 | 310.15 | 44.94 | 65.96 | 422.78 |
| Change | -0.0200 | -2.71 | +0.20 | +1.38 | +3.79 |
| % Change | -1.75% | -0.87% | +0.45% | +2.14% | +0.90% |
| Volume | 531,700 | 2,611,800 | 8,699,500 | 8,733,200 | 1,064,600 |
| 20-Day Average Volume | 1,080,175 | 2,930,860 | 14,168,375 | 7,614,375 | 1,107,780 |
| Previous Close | 1.1400 | 312.86 | 44.74 | 64.58 | 418.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0944 | 281.61 | 46.01 | 65.99 | 401.94 |
| 20-Day Raw Stochastic | 65.60% | 79.89% | 25.81% | 39.52% | 91.71% |
| 20-Day Relative Strength | 45.62% | 65.95% | 36.90% | 39.82% | 62.31% |
| Weighted Alpha | -42.10 | +34.03 | -34.29 | -19.29 | +22.92 |
| Today's Opinion | 24% Buy | 56% Buy | 100% Sell | 100% Sell | 56% Buy |
| Previous Opinion | 40% Buy | 56% Buy | 100% Sell | 100% Sell | 56% Buy |
| Last Month's Opinion | 56% Buy | 40% Sell | 56% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.88% since 05/03/24 | -0.37% since 05/03/24 | +2.16% since 05/03/24 | +1.82% since 05/03/24 | +5.41% since 05/03/24 |
| Low | 1.0200 on 05/08/24 | 297.52 on 05/06/24 | 43.49 on 05/09/24 | 64.34 on 05/06/24 | 394.03 on 05/07/24 |
| High | 1.2300 on 05/06/24 | 314.89 on 05/10/24 | 44.97 on 05/10/24 | 66.20 on 05/10/24 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -11.81% since 04/10/24 | +16.40% since 04/10/24 | -10.64% since 04/10/24 | -3.17% since 04/10/24 | +6.34% since 04/10/24 |
| Low | 0.8721 on 04/18/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 1.3400 on 04/11/24 | 322.60 on 05/03/24 | 50.58 on 04/11/24 | 69.03 on 04/11/24 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | -10.40% since 02/09/24 | +6.54% since 02/09/24 | -9.78% since 02/09/24 | -10.47% since 02/09/24 | -0.03% since 02/09/24 |
| Low | 0.8721 on 04/18/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 2.0500 on 03/08/24 | 322.60 on 05/03/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | +138.25% since 11/10/23 | +16.03% since 11/10/23 | -11.20% since 11/10/23 | -13.12% since 11/10/23 | +13.15% since 11/10/23 |
| Low | 0.4200 on 11/28/23 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 2.0500 on 03/08/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 281,381 | 167,829,040 | 90,692,464 | 80,407,072 | 108,121,632 |
| Shares Outstanding, K | 246,825 | 536,435 | 2,027,100 | 1,245,077 | 258,053 |
| Annual Sales | 60,280,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -113,870,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 230,000 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -47,920,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 2.44 | 0.60 | 0.45 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 03/06/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/15/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 41.59 | 16.11 | 27.81 |